SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-085446
Filing Date
2022-08-03
Accepted
2022-08-03 07:35:08
Documents
15
Period of Report
2022-08-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2222182d1_8k.htm   iXBRL 8-K 35901
2 EXHIBIT 99.1 tm2222182d1_ex99-1.htm EX-99.1 81710
3 EXHIBIT 99.2 tm2222182d1_ex99-2.htm EX-99.2 14842
7 GRAPHIC tm2222182d1_ex99-1img001.jpg GRAPHIC 5079
  Complete submission text file 0001104659-22-085446.txt   333962

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA knsa-20220802.xsd EX-101.SCH 3030
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE knsa-20220802_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE knsa-20220802_pre.xml EX-101.PRE 22593
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2222182d1_8k_htm.xml XML 3611
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38492 | Film No.: 221130938
SIC: 2834 Pharmaceutical Preparations